Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-4
Publisher
Informa UK Limited
Online
2018-07-24
DOI
10.1080/10428194.2018.1485913
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer
- (2018) Tilly Varughese et al. CLINICAL INFECTIOUS DISEASES
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study
- (2016) Maria Chiara Tisi et al. HAEMATOLOGICA
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study
- (2016) Maria Chiara Tisi et al. HAEMATOLOGICA
- Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions
- (2014) M. Levade et al. BLOOD
- Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
- (2013) Akintunde Akinleye et al. Journal of Hematology & Oncology
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
- (2012) C. Bodur et al. CURRENT MEDICINAL CHEMISTRY
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas
- (2011) Q. Yan et al. HAEMATOLOGICA
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- New and emerging treatments for fungal infections
- (2007) A. C. Pasqualotto et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started